Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
2 April 2014
P-004138-14
Question for written answer
to the Commission
Rule 117
James Nicholson (ECR)

 Subject:  Special labelling provision for rapeseed protein as a novel food
 Answer(s) 

I welcome the forthcoming authorisation of rapeseed protein as a novel food; however, the draft Commission implementing decision contains an unprecedented labelling provision according to which ‘any foodstuff containing rapeseed protein shall bear an easily visible and legible statement that the product containing “rapeseed protein” as a food ingredient may cause allergic reaction to consumers who are allergic to mustard and products thereof’.

If rapeseed protein is considered an allergen, then it should be listed in Annex II to Regulation (EU) No 1169/2011 on the provision of food information to consumers. If rapeseed protein is not an allergen, it should not be subject to a special labelling requirement.

Will the Commission explain why it has proposed a labelling requirement for allergic cross-reaction as opposed to the traditional professional information channels to inform consumers?

Can the Commission confirm that such a labelling requirement has a legal basis in the current novel foods regulation?

Will the Commission take into consideration the European Food Safety Authority’s anticipated report on the occurrence of food allergies in the EU before imposing unprecedented labelling requirements?

 OJ C 367, 16/10/2014
Last updated: 10 April 2014Legal notice